3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsHemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndromeRecruitingPhase 32026-10-08NCT06499285
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Studycancer, neoplasmRecruitingPhase 32026-10-02NCT05862285
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDNeovascular Age-related Macular DegenerationRecruitingPhase 32026-09-21NCT06847542